Novel CAR-T cell platform designed to selectively eliminate disease-driving bone marrow-derived myeloid cells in the central nervous system. Based on proprietary transcriptomic and epigenomic signatures distinguishing pa...
Innovative stabilized nanoparticles enhance tissue-specific gene delivery by combining covalent and electrostatic conjugation. This approach aims to improve drug-nanoparticle stability and specificity, enabling targeted ...
Exploring DRP1 as a target to inhibit metabolic reprogramming in dormant HER2+ breast cancer cells, potentially reducing brain metastasis by affecting mitochondrial plasticity and fatty acid oxidation.
UT Southwestern Medical Center develops advanced non-viral delivery platforms, including Selective Organ Targeting (SORT) lipid nanoparticles, to enable precise, systemic delivery of genetic medicines like mRNA and CRISP...
A research initiative developing highly potent, species-selective, and orally active reversible inhibitors of the Plasmodium falciparum 20S proteasome. Designed to treat malaria while avoiding human proteasome cross-inhi...